招股文件
泰格医药全球发售招股书
2020/07/28
[发售以供认购] – 白色申请表格
2020/07/28
[发售以供认购] – 黄色申请表格
2020/07/28
[发售以供认购] – 绿色申请表格
2020/07/28
2020/07/28
2020/07/28
2020/07/28
2020/07/28
国家药监局药审中心2020年11月19日正式发布了《药品附条件批准上市技术指导原则(试行)》。提出鼓励以临床价值为导向的药物创新,对临床急需的创新药加快审评。
泰格医药首席科学官杨见松博士,与您分享为何应将中国纳入您未来的药物全球开发策略中,以及相关的政策和科学解读。
抗肿瘤药是当前全球新药研发的热点之一,越来越多基于医学影像评估结果的替代终点,正在成为支持新药上市的关键研究的主要终点。
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.